Wilson Sonsini Goodrich & Rosati advised ALX Oncology Holdings Inc. on the offering, and Cooley advised the underwriters. ALX Oncology Holdings Inc. (Nasdaq:ALXO) announced the pricing...
ALX Oncology’s $63 Million Common Stock Offering
ALX Oncology’s Acquisition of ScalmiBio
Wilson Sonsini Goodrich & Rosati advised ALX Oncology on the deal. ALX Oncology Holdings Inc. (ALX Oncology), a clinical-stage immuno-oncology company, and ScalmiBio, Inc., announced that...